openPR Logo
Press release

Hematopoietic Stem Cell Transplantation Market Anticipates Impressive Growth Trajectory Through 2032 - Asserts DelveInsight | Actinium, Athersys, BioLineRX, CareDex, Graphite Bio, Mana Therapeutics, Medac Pharma, Medexus Pharmaceuticals, Vor Biopharma

08-08-2023 07:21 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Hematopoietic Stem Cell Transplantation Market Anticipates

The Hematopoietic Stem Cell Transplantation (HSCT) market size in the 7MM was observed to be USD 763 million in 2021. The HSCT market is anticipated to evolve immensely in the coming years owing to the advances in mechanisms that have yielded new diagnostic and therapeutic approaches, opening the way to more medical development.

Moreover, the increasing cases and the launch of upcoming therapies during the forecast period are also expected to drive the Hematopoietic Stem Cell Transplantation (HSCT) Market growth. The current market anticipates the emergence of products, namely Iomab-B (Actinium Pharmaceuticals), Motixafortide (BioLineRx), and treosulfan (Medexus Pharmaceuticals /medac Pharma). Currently, key players, such as Actinium Pharmaceuticals, BioLineRX, and others, are involved in developing therapies that cater to the procedure of HSCT.

DelveInsight's "Hematopoietic Stem Cell Transplantation Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Hematopoietic Stem Cell Transplantation Market Size and Share in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).

The market report covers emerging drugs, treatment practices, market share of individual Hematopoietic Stem Cell Transplantation therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Hematopoietic Stem Cell Transplantation treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market.

Hematopoietic Stem Cell Transplantation (HSCT): An Overview
Hematopoietic stem cell transplantation (HSCT) administers healthy hematopoietic stem cells (HSC) to patients with defective or depleted bone marrow. This improves bone marrow function and, depending on the disease being treated leads to either the destruction of malignant tumor cells or the generation of functional cells that can replace the dysfunctional ones, as in the case of immune-deficiency syndromes, hemoglobinopathies, and other diseases.

HSCs are immature blood cells in the peripheral and bone marrow. These are also called blood stem cells. These are produced in the bone marrow and can develop into any type of blood cell required by the body. Stem cells divide and mature, replacing older and worn-out blood cells. Many major health issues can emerge if the stem cells cannot produce enough new blood cells. Infections, anemia, and bleeding are examples of such issues. Healthy stem cells are required for survival. Stem cell transplantation (SCT) may be the best therapy option when cancer or cancer therapies eliminate the stem cells.

Hematopoietic Stem Cell Transplantation (HSCT) Market Key Facts
• In 2021, the US had the largest Hematopoietic Stem Cell Transplantation market size of USD 491 million among the 7MM countries.
• Among the EU-5 countries, Germany had the highest market size for Hematopoietic Stem Cell Transplantation in 2021, i.e., USD 62 million. The lowest market size was estimated in Spain, with USD 30 million in 2021.
• In Japan, the market size for Hematopoietic Stem Cell Transplantation was observed to be USD 47 million in 2021.
• In 2021, the total number of cases of Hematopoietic Stem Cell Transplantation in the 7MM countries was 55,000+, and these cases are anticipated to increase during the study period. The US accounted for 23,900+ cases of HSCT in 2021.
• Among the European countries, Germany had the highest number of Hematopoietic Stem Cell Transplantation cases in 2021, i.e., 7,000+ cases, followed by Italy, which had 5,600+ cases in 2021. On the other hand, Spain had the lowest number of cases of Hematopoietic Stem Cell Transplantation in 2021.
• In terms of type-specific cases of Hematopoietic Stem Cell Transplantation, the percentage of autologous HSCT cases is higher than allogeneic Hematopoietic Stem Cell Transplantation across the 7MM except for Japan.

Discover How Hematopoietic Stem Cell Transplantation Market Will Grow by 2032:
https://www.delveinsight.com/report-store/hematopoietic-stem-cell-transplantation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Hematopoietic Stem Cell Transplantation Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted market size by analyzing the impact of current and emerging Hematopoietic Stem Cell Transplantation therapies in the market. It also provides a detailed assessment of the Hematopoietic Stem Cell Transplantation market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the market trend for each marketed Hematopoietic Stem Cell Transplantation drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MOA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Hematopoietic Stem Cell Transplantation Epidemiology
The epidemiology section covers detailed insights into the historical, and current Hematopoietic Stem Cell Transplantation patient pool and forecasted epidemiology trends for every seven major countries (7MM) from 2019 to 2032.

The Report Covers the Hematopoietic Stem Cell Transplantation Epidemiology Segmented as -
• Type-specific Cases of Hematopoietic Stem Cell Transplantation (HSCT) in the 7MM [2019-2032]
• Total Cases of Hematopoietic Stem Cell Transplantation (HSCT) in the 7MM [2019-2032]
• Total Cases of Hematopoietic Stem Cell Transplantation (HSCT) by Indications in the 7MM [2019-2032]

Get Key Insights Into the Evolving Hematopoietic Stem Cell Transplantation Epidemiology Trends @
https://www.delveinsight.com/report-store/hematopoietic-stem-cell-transplantation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Hematopoietic Stem Cell Transplantation Drugs Uptake and Pipeline Development Activities
The drugs' uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hematopoietic Stem Cell Transplantation market or expected to be launched during the study period. The analysis covers the market share by Hematopoietic Stem Cell Transplantation drugs, patient uptake by therapies, and sales of each drug.

The report's drugs uptake section helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs. It allows the comparison of the drugs based on market share and size, which again will be helpful in investigating factors important in understanding the market dynamics and in making financial and regulatory decisions.

The report also covers the Hematopoietic Stem Cell Transplantation Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Explore More About Ongoing Pipeline Development Activities @
https://www.delveinsight.com/sample-request/hematopoietic-stem-cell-transplantation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Hematopoietic Stem Cell Transplantation Therapeutics Assessment
Several major pharma and biotech giants are developing therapies for Hematopoietic Stem Cell Transplantation. Currently, Actinium Pharmaceuticals is leading the therapeutics market with its Hematopoietic Stem Cell Transplantation drug candidates in the most advanced stage of clinical development.

Leading Companies in the Hematopoietic Stem Cell Transplantation (HSCT) Market Include:
• Actinium Pharmaceuticals
• Athersys
• BioLineRX
• CareDex
• Garuda Therapeutics
• Graphite Bio
• Jasper Therapeutics
• Magenta Therapeutics
• Mana therapeutics
• Medac Pharma
• Medexus Pharmaceuticals
• Novartis
• Orchard Therapeutics
• SANOFI
• Vor Biopharma
And Many Others

Hematopoietic Stem Cell Transplantation (HSCT) Emerging and Marketed Drugs Covered in the Report Include:
• IOMAB-B (CD45) (APAMISTAMAB-I-131): Actinium Pharmaceuticals
• MANA-312: Mana therapeutics
• Motixafortide (BL-8040): BioLineRX
• MOZOBIL (PLERIXAFOR): SANOFI
• TRECONDI (TREOSULFAN): Medexus Pharmaceuticals /Medac Pharma
And Many More

Learn More About the Emerging Therapies & Key Companies in the Hematopoietic Stem Cell Transplantation Therapeutics Market:
https://www.delveinsight.com/sample-request/hematopoietic-stem-cell-transplantation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Hematopoietic Stem Cell Transplantation Competitive Intelligence Analysis
4. Hematopoietic Stem Cell Transplantation Market Overview at a Glance
5. Hematopoietic Stem Cell Transplantation Background and Overview
6. Hematopoietic Stem Cell Transplantation Patient Journey
7. Hematopoietic Stem Cell Transplantation Epidemiology and Patient Population
8. Hematopoietic Stem Cell Transplantation Treatment Algorithm, Current Treatment, and Medical Practices
9. Hematopoietic Stem Cell Transplantation Unmet Needs
10. Key Endpoints of Hematopoietic Stem Cell Transplantation Treatment
11. Hematopoietic Stem Cell Transplantation Marketed Products
12. Hematopoietic Stem Cell Transplantation Emerging Therapies
13. Hematopoietic Stem Cell Transplantation Seven Major Market Analysis
14. Attribute Analysis
15. Hematopoietic Stem Cell Transplantation Market Outlook (7 major markets)
16. Hematopoietic Stem Cell Transplantation Access and Reimbursement Overview
17. KOL Views on the Hematopoietic Stem Cell Transplantation Market.
18. Hematopoietic Stem Cell Transplantation Market Drivers
19. Hematopoietic Stem Cell Transplantation Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.

Download the Sample PDF to Get Detailed Insights About the Report's Offerings @
https://www.delveinsight.com/sample-request/hematopoietic-stem-cell-transplantation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Mucinous Cystic Neoplasms (MCNs) Market
https://www.delveinsight.com/report-store/mucinous-cystic-neoplasms-mcns-market

Overt Hepatic Encephalopathy Market
https://www.delveinsight.com/report-store/overt-hepatic-encephalopathy-market

Familial Hypercholesterolemia Market
https://www.delveinsight.com/report-store/familial-hypercholesterolemia-market-report

Lateral Epicondylitis (Tennis Elbow) Disease Market
https://www.delveinsight.com/report-store/lateral-epicondylitis-tennis-elbow-disease-market

Diverticulitis Market
https://www.delveinsight.com/report-store/diverticulitis-market

Crows Feet Market
https://www.delveinsight.com/report-store/crows-feet-market

Helicobacter Pylori Infections Market
https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market

Charcot-Marie-Tooth Disease Market
https://www.delveinsight.com/report-store/charcot-marie-tooth-disease-market

Neurovascular Thrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Neurothrombectomy Devices Market
https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market

Stargardt Disease (STGD) Market
https://www.delveinsight.com/report-store/stargardt-disease-stgd-market

Venous Leg Ulcer Market
https://www.delveinsight.com/report-store/venous-leg-ulcer-market

Genital Herpes Market
https://www.delveinsight.com/report-store/genital-herpes-market-forecast

Idiopathic Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/idiopathic-thrombocytopenic-purpura-market

Morquio Syndrome Market
https://www.delveinsight.com/report-store/morquio-syndrome-market

Lymphoedema Market
https://www.delveinsight.com/report-store/lymphoedema-market

Neurotrophic Keratopathy Market
https://www.delveinsight.com/report-store/neurotrophic-keratopathy-market

Oncolytic Virus Cancer Therapy Market
https://www.delveinsight.com/report-store/oncolytic-virus-cancer-therapy-market

Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market

Advanced Wound Care (AWC) Market
https://www.delveinsight.com/report-store/advanced-wound-care-market

Opioid-related Disorders Market
https://www.delveinsight.com/report-store/opioid-related-disorders-market

Ankylosing Spondylitis (AS) Market
https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market

Chronic Insomnia Market
https://www.delveinsight.com/report-store/chronic-insomnia-market

Microscopic Polyangiitis (MPA) Market
https://www.delveinsight.com/report-store/microscopic-polyangiitis-mpa-market

Esophageal Squamous Carcinoma Market
https://www.delveinsight.com/report-store/esophageal-squamous-carcinoma-market

Hypertrophic Scar Market
https://www.delveinsight.com/report-store/hypertrophic-scar-market

Chemotherapy Induced Neutropenia (CIN) Market
https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market

Idiopathic Interstitial Pneumonia Market
https://www.delveinsight.com/report-store/idiopathic-interstitial-pneumonia-market

Diphtheria Market
https://www.delveinsight.com/report-store/diphtheria-market

Dyslipidemia Market
https://www.delveinsight.com/report-store/dyslipidemia-market

Thymus Cancer Market
https://www.delveinsight.com/report-store/thymus-cancer-market

Tendonitis Market
https://www.delveinsight.com/report-store/tendonitis-market

Alpha-Antitrypsin Deficiency Market
https://www.delveinsight.com/report-store/alpha-antitrypsin-deficiency-market

Contact Info:
Shruti Thakur
Manager (Marketing & Branding)
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hematopoietic Stem Cell Transplantation Market Anticipates Impressive Growth Trajectory Through 2032 - Asserts DelveInsight | Actinium, Athersys, BioLineRX, CareDex, Graphite Bio, Mana Therapeutics, Medac Pharma, Medexus Pharmaceuticals, Vor Biopharma here

News-ID: 3158980 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Stem

Animal Stem Cell Therapy Market Worth Observing Growth| Cell Therapy Sciences, M …
Advance Market Analytics published a new research publication on "Animal Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world. Some of
Introducing My STEM Resume: The Ultimate Solution for STEM Professionals
As STEM industries continue to grow, so does the demand for qualified professionals. Yet, many STEM students and professionals face challenges in effectively showcasing their skills and experience to prospective employers. Recognizing this need, Brendon, a seasoned STEM professional, has developed a groundbreaking solution: My STEM Resume. My STEM Resume is a cutting-edge app designed specifically for STEM professionals, offering a comprehensive suite of tools to streamline the resume creation and
Animal Stem Cell Therapy Market 2022: Allogeneic Stem Cells Popular Sourcing Cho …
The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032). Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941 Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that
Animal Stem Cell Therapy Market 2021 Research Report by Experts- Magellan Stem C …
Global Animal Stem Cell Therapy Market Size, Status and Forecast 2022 The Global Animal Stem Cell Therapy Market Research Report 2022-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive
Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues. Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports. Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process